연구성과로 돌아가기
2022 연구성과별 연구자 정보 (965 / 2879)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Kang, Yoon-Koo | Kang, YK | 1 | 교신저자 | Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea | ABL-4264-2022 | Kang, Yoon-Koo | 0000-0003-0783-6583 | Kang, Yoon-Koo | ykkang@amc.seoul.kr; |
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Morita, Satoshi | Morita, S | 2 | Kyoto Univ, Dept Biomed Stat & Bioinformat, Grad Sch Med, Kyoto, Japan | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Satoh, Taroh | Satoh, T | 3 | Osaka Univ, Frontier Sci Canc & Chemotherapy, Grad Sch Med, Suita, Osaka, Japan | AAF-5193-2021 | Satoh, Taroh | ykkang@amc.seoul.kr; | |||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Ryu, Min-Hee | Ryu, MH | 4 | Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Chao, Yee | Chao, Y | 5 | Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Kato, Ken | Kato, K | 6 | Natl Canc Ctr, Div Gastrointestinal Med Oncol, Tokyo, Japan | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Chung, Hyun Cheol | Chung, HC | 7 | Yonsei Univ, Yonsei Canc Ctr, Dept Internal Med, Coll Med, Seoul, South Korea | AFB-8969-2022 | Chung, Hyun Cheol | ykkang@amc.seoul.kr; | |||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Chen, Jen-Shi | Chen, JS | 8 | Chang Gung Univ, Linkou Chang Gung Mem Hosp, Dept Internal Med, Div Hematol & Oncol, Taoyuan, Taiwan | GLV-3349-2022 | Chen, Jen-Shi | ykkang@amc.seoul.kr; | |||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Muro, Kei | Muro, K | 9 | Aichi Canc Ctr Hosp, Dept Clin Oncol, Nagoya, Aichi, Japan | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Kang, Won Ki | Kang, WK | 10 | Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Hematol Oncol,Sch Med, Seoul, South Korea | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Yeh, Kun-Huei | Yeh, KH | 11 | Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan | HGD-3316-2022 | Yeh, Kun-Huei | ykkang@amc.seoul.kr; | |||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Yoshikawa, Takaki | Yoshikawa, T | 12 | Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa, Japan | Y-1580-2019 | Yoshikawa, Takaki | ykkang@amc.seoul.kr; | |||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Yoshikawa, Takaki | Yoshikawa, T | 12 | Natl Canc Ctr, Dept Gastr Surg, Tokyo, Japan | Y-1580-2019 | Yoshikawa, Takaki | ykkang@amc.seoul.kr; | |||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Oh, Sang Cheul | Oh, SC | 13 | Korea Univ, Coll Med, Dept Internal Med, Div Hematol & Oncol, Seoul, South Korea | ykkang@amc.seoul.kr; | |||||
| Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study | Bai, Li-Yuan | Bai, LY | 14 | China Med Univ, China Med Univ Hosp, Dept Internal Med, Div Hematol & Oncol, Taichung, Taiwan | ykkang@amc.seoul.kr; |
페이지 이동: